Musk v. Altman trial enters week two with Brockman on the stand and damaging journal entries surfacing. Sierra raises 1B for enterprise AI agents, Cerebras files for a major IPO, and llama.cpp may double local inference speeds.

Harvard study shows AI outdiagnosing ER doctors, plus AI detects pancreatic cancer early and a BBC investigation reveals chatbots triggering dangerous delusions.

DeepSeek V4 and Kimi K2.6 challenge frontier labs on price and benchmarks, a Hawley bill to ID-verify chatbot users clears committee, and Microsoft quietly attributed commits to Copilot without its use.

Pentagon expands classified AI vendors while excluding Anthropic over weapons restrictions, xAI launches Grok 4.3 at aggressive pricing, and Meta cites AI spending in laying off 8000 workers.

Anthropic nears a 900B valuation, Musk admits xAI distilled OpenAI models while accusing DeepSeek of the same, and Claude Code may be penalizing users who mention rival AI tools.

Mistral dropped a dense 128B Medium 3.5 with 256k context, IBM refreshed Granite 4.1, and Elon Musk had a rough day testifying in the OpenAI trial. Nvidia admits compute now costs more than the humans.

Google signs classified Pentagon AI deal as Musk testifies against Altman in court. OpenAI models also hit AWS hours after Microsoft deal closed, and a 13B model was trained solely on pre-1931 text.

Microsoft and OpenAI tore up their AGI clause and exclusive deal, while China blocked Metas 2B Manus acquisition reportedly using founders families as leverage. Musk vs Altman heads to jury trial.

23-year-old cracks 60-year-old Erdos conjecture with ChatGPT, OpenAI abandons SWE-Bench amid saturation concerns, and an AI agent deletes a production database.

Cohere acquires Aleph Alpha at 20B valuation for sovereign AI play, DeepSeek V4 Pro draws criticism for inefficiency vs GPT-5.5, and Anthropic tests agent-on-agent commerce.